Guardian Pharmacy converts 1.41M insider shares

Q: How many GRDN shares did Pharmacy Investors convert?

Pharmacy Investors, LLC converted 1,413,939 Class B common shares into 1,413,939 Class A common shares on September 27, 2026, automatically and on a one-for-one basis under the issuer’s Amended and Restated Certificate of Incorporation.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Pharmacy Investors, LLC, identified as a member of Guardian Pharmacy Services, Inc.’s 10% owner group, reported the automatic conversion of 1,413,939 Class B common shares into 1,413,939 Class A common shares on September 27, 2026, on a one-for-one basis under the issuer’s Amended and Restated Certificate of Incorporation. Following the conversion, it reported 3,863,806 Class A shares and zero Class B shares.

Insider Trade Summary

1,413,939 shares exercised/converted

Exercise 2 txns

Insider Pharmacy Investors, LLC

Role Insider

Type	Security	Shares	Price	Value
Exercise	Class B Common Stock ^F1	1,413,939	--	--
Exercise	Class A Common Stock ^F1	1,413,939	--	--

Holdings After Transaction: Class B Common Stock — 0 contracts (Direct); Class A Common Stock — 3,863,806 shares (Direct)

Footnotes (1)

F1. Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically converted into shares of the Issuer's Class A common stock, on a one-for-one basis, on September 27, 2026.

Key Figures

Class B common shares converted: 1,413,939 shares Class A common shares acquired in conversion: 1,413,939 shares Class A common shares following conversion: 3,863,806 shares +1 more

4 metrics

Class B common shares converted 1,413,939 shares September 27, 2026

Class A common shares acquired in conversion 1,413,939 shares September 27, 2026

Class A common shares following conversion 3,863,806 shares Following the September 27, 2026 conversion

Class B common shares following conversion 0 shares Following the September 27, 2026 conversion

Key Terms

Class B common stock, Class A common stock, one-for-one basis, Amended and Restated Certificate of Incorporation

4 terms

Class B common stock financial

"shares of Class B common stock automatically converted"

A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.

Class A common stock financial

"into shares of the Issuer's Class A common stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

one-for-one basis financial

"on a one-for-one basis"

Amended and Restated Certificate of Incorporation technical

"Pursuant to the Issuer's Amended and Restated Certificate of Incorporation"

A company’s amended and restated certificate of incorporation is an updated version of its foundational legal charter that replaces the older document and folds in all changes into one clear copy; it spells out corporate structure, classes of stock, shareholder rights and key governance rules. Investors care because it can change who controls the company, how votes are counted, what claims shareholders have on assets or dividends, and can introduce or remove protections against takeovers—like updating a house title after a major renovation to show who owns what and under what rules.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GRDN shares did Pharmacy Investors convert?

Pharmacy Investors, LLC converted 1,413,939 Class B common shares into 1,413,939 Class A common shares on September 27, 2026, automatically and on a one-for-one basis under the issuer’s Amended and Restated Certificate of Incorporation.

What GRDN shares did Pharmacy Investors hold after the conversion?

After the September 27, 2026 conversion, Pharmacy Investors, LLC reported 3,863,806 Class A common shares and zero Class B common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 09/28/2026 - 05:12 PM Accepted by SEC EDGAR 09/28/2026 - 05:12 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pharmacy Investors, LLC

(Last)

(First)

(Middle)

401 PENNSYLVANIA PARKWAY, SUITE 115

(Street)

INDIANAPOLIS

INDIANA

46280

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardian Pharmacy Services, Inc. [ GRDN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director		10% Owner
Officer (give title below)	X	Other (specify below)
		Member of 10% Owner Group

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	09/27/2026		M		1,413,939	A	⁽¹⁾	3,863,806	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Class B Common Stock	⁽¹⁾	09/27/2026		M			1,413,939	⁽¹⁾	⁽¹⁾	Class A Common Stock	1,413,939	⁽¹⁾	0	D

Explanation of Responses:

1. Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically converted into shares of the Issuer's Class A common stock, on a one-for-one basis, on September 27, 2026.

	/s/ Douglas Towns, Attorney-in-Fact	09/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR